Scientists track HPV vaccine protection in High-Risk women
NCT ID NCT05247853
Summary
This study examines how well the HPV vaccine protects against infections that can lead to cervical cancer over many years. Researchers followed 3,127 Rwandan women aged 18-28, including those living with and without HIV, to compare infection rates between vaccinated and unvaccinated groups. The research aims to understand long-term vaccine effectiveness in populations at highest risk for HPV-related cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rwanda Military Hospital
Kigali, Rwanda
Conditions
Explore the condition pages connected to this study.